Diverse effects of monensin on capacitative Ca2+ entry and release of stored Ca2+ in vascular smooth muscle cells

European Journal of Pharmacology

Volumn 464, Issue 1, 2003, Pages 27-31

  Wakabayashi, Ichiro ^a   Marumo, Mikio ^a   Sotoda, Yoko ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Ca2+ channel; Ca2+ entry, capacitative; Inositol 1,4,5 trisphosphate; Monensin; Smooth muscle, vascular; Vasoconstriction

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; CALCIUM ION; INOSITOL PHOSPHATE; MONENSIN; SEROTONIN; THAPSIGARGIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0037424426     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01372-4     Document Type: Article

References (23)

1. Abdel-Latif A.A. Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. Pharmacol. Rev. 38:1986;227-272.
2. + exchange in cultured vascular smooth muscle cells. Evidence for protein kinase C-dependent and -independent pathways. J. Biol. Chem. 262:1987;5057-5064.
3. Berridge M.J., Downes C.P., Hanley M.R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206:1982;587-595.
4. Catalan R.E., Martinez A.M., Aragones M.D., Hernandez F. Regulation of phosphoinositide cycle by intracellular sodium in the blood-brain barrier. Cell. Signal. 8:1996;387-392.
5. 2+ channels in arterial smooth muscle cells. Kidney Blood Press. Res. 20:1997;355-371.
6. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
7. Gusovsky F., McNeal E.T., Daly J.W. Stimulation of phosphoinositide breakdown in brain synaptoneurosomes by agents that activate sodium influx: antagonism by tetrodotoxin, saxitoxin, and cadmium. Mol. Pharmacol. 32:1987;479-487.
8. +-proton exchanger. Circ. Res. 76:1995;148-153.
9. + exchange and vascular smooth muscle proliferation. Am. J. Med. Sci. 307(Suppl. 1):1994;S9-S16.
10. McFadzean I., Gibson A. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br. J. Pharmacol. 135:2002;1-13.
11. Merritt J.E., Armstrong W.P., Benham C.D., Hallam T.J., Jacob R., Jaxa-Chamiec A., Leigh B.K., McCarthy S.A., Moores K.E., Rink T.J. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J. 271:1990;515-522.
12. 2+ entry channels in rat thoracic aortic smooth muscle cells activated by endothelin-1. Jpn. J. Pharmacol. 80:1999;281-288.
13. + antiport activity in human hypertension. J. Hypertens. 7:1989;471-475.
14. Putney J.W. Jr. A model for receptor-regulated calcium entry. Cell Calcium. 7:1986;1-12.
15. Putney J.W. Jr. Type 3 inositol 1,4,5-trisphosphate receptor and capacitative calcium entry. Cell Calcium. 21:1997;257-261.
16. Rasmussen H., Takuwa Y., Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB J. 1:1987;177-185.
17. + exchanger activity in normotensive and hypertensive subjects: effect of enalapril therapy upon antiport activity. J. Hypertens. 10:1992;839-847.
18. + antiporter, glycoprotein of 110 kD. Science. 247:1990;723-726.
19. + exchange in patients with essential hypertension. Am. J. Hypertens. 2:1989;903-908.
20. + exchanger isoform 1. Hypertension. 27:1996;859-866.
21. 2+-ATPases. Trends Pharmacol. Sci. 19:1998;131-135.
22. 2+ exchanger of the human platelet. J. Membr. Biol. 130:1992;63-82.
23. 2+ channels. Eur. J. Pharmacol. 428:2001;251-259.